Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.33 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26996636 | 0.88 | AR (0.38) | ARHPGDNPSR1MCOLN3RAPGEF4 | |
| SCHEMBL21913732 | 0.85 | RAPGEF4 (0.38) | ARHPGDNPSR1MCOLN3RAPGEF4 | |
| SCHEMBL13338373 | 0.85 | AR (0.45) | ARALDH1A1TSHR | |
| SCHEMBL24237256 | 0.83 | ALDH1A1 (0.39) | ARHPGDNPSR1MCOLN3RAPGEF4 | |
| SCHEMBL26996634 | 0.81 | DHFR (0.38) | HPGDNPSR1MCOLN3ALDH1A1KDM4E | |
| SCHEMBL13338508 | 0.76 | ALDH1A1 (0.41) | ARNPSR1MCOLN3RAPGEF4ALDH1A1 | |
| SCHEMBL13338389 | 0.74 | ALDH1A1 (0.41) | ARALDH1A1KDM4ELMNAMAPT | |
| SCHEMBL24237326 | 0.74 | ALDH1A1 (0.38) | ARRAPGEF4ALDH1A1LMNATSHR | |
| SCHEMBL13338573 | 0.74 | SLC6A2 (0.35) | ARALDH1A1TSHR | |
| SCHEMBL13338576 | 0.72 | ACHE (0.48) | ARALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877506-B2 | Polycyclic aromatic compound | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11877506-B2 | Polycyclic aromatic compound | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2024-01-16 | — | — | US | disclosed |
| US-20220037591-A1 | Polycyclic aromatic compound | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11877506-B2 | Polycyclic aromatic compound | F11, C1R, RNF31 | AR 458/4885HPGD 1870/4885NPSR1 469/4885 |
| US-20220037591-A1 | Polycyclic aromatic compound | F11, C1R, RNF31 | AR 458/4885HPGD 1870/4885NPSR1 469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.